The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service
2020-01-01 Jommi, Claudio; Cipriani, Filippo; Fanelli, Francesca; Pedone, Maria Paola; Canonica, Walter
Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: analisi delle tempistiche di valutazione dellAgenzia Italiana del Farmaco
2018-01-01 Lidonnici, Dario; Ronco, Virginia; Isernia, Martina; Lanati, Elena; Jommi, Claudio; Canonico, Pier Luigi; Genazzani, Armando A.
Management of technological innovations in health care: Analysis and comparison of some regional policies in Italy
2010-01-01 Cavallo, M. C.; Ciani, O.; Gugiatti, A.; Jommi, C.; Tarricone, R.
Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives
2018-01-01 Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio
Establishing the value of new drugs in Italy
2020-01-01 Villa, F.; Jommi, C.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.
Variations in non-prescription drug consumption and expenditure: Determinants and policy implications
2018-01-01 Otto, M.; Armeni, P.; Jommi, C.
Costs of patients suffering from multiple sclerosis in piedmont region: Evidence from administrative databases
2012-01-01 Roggeri, D. P.; Roggeri, A.; Jommi, C.
De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making
2016-01-01 Ciani, O.; Armeni, P.; Boscolo, P. R.; Cavazza, M.; Jommi, C.; Tarricone, R.
Patient access to oral nutritional supplements: Which policies count?
2020-01-01 Cavazza, M.; Banks, H.; Muscaritoli, M.; Rondanelli, M.; Zandona, E.; Jommi, C.
Generic preference-based measures for low back pain
2016-01-01 Finch, A. P.; Dritsaki, M.; Jommi, C.
The association of financial difficulties with clinical outcomes in cancer patients: Secondary analysis of 16 academic prospective clinical trials conducted in Italy
2016-01-01 Perrone, F.; Jommi, C.; Di Maio, M.; Gimigliano, A.; Gridelli, C.; Pignata, S.; Ciardiello, F.; Nuzzo, F.; de Matteis, A.; Del Mastro, L.; Bryce, J.; Daniele, G.; Morabito, A.; Piccirillo, M. C.; Rocco, G.; Guizzaro, L.; Gallo, C.
Health care costs of influenza-related episodes in high income countries: A systematic review
2018-01-01 Federici, C.; Cavazza, M.; Costa, F.; Jommi, C.
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals
2019-01-01 Jommi, Claudio; Cavazza, Marianna
Costs of patients suffering from multiple sclerosis in piedmont region: Evidence from administrative databases
2012-01-01 Roggeri, D. P.; Roggeri, A.; Jommi, C.
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system
2021-01-01 Riva, S.; Efficace, F.; Di Maio, M.; Bryce, J.; Del Campo, L.; De Lorenzo, F.; Frontini, L.; Giannarelli, D.; Gitto, L.; Iannelli, E.; Jommi, C.; Montesarchio, V.; Traclo, F.; Vaccaro, C. M.; Arenare, L.; Canzanella, G.; Gimigliano, A.; Romano, F.; Savio, A.; Sparavigna, L.; Piccirillo, M. C.; Guizzaro, L.; Gallo, C.; Perrone, F.
The impact of HTA and procurement practices on the selection and prices of medical devices
2017-01-01 Callea, G.; Armeni, P.; Marsilio, M.; Jommi, C.; Tarricone, R.
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
2023-01-01 Tarantola, A.; Otto, M. H.; Armeni, P.; Costa, F.; Malandrini, F.; Jommi, C.
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service
2020-01-01 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Colombo, N.; Costa, F.
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital
2014-01-01 Costa, E.; Biasi, V.; Concia, E.; Jommi, C.; Lattuada, E.; Manfre, S.; Venturini, F.; Lanzafame, M.
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study
2016-01-01 Armeni, P.; Jommi, C.; Otto, M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista36149
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa64
- 2020 - 20269888
- 2010 - 201913041
- 2000 - 20097282
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...164
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19344
- Italy298
- Animals217
- Treatment Outcome196
Lingua
- eng24750
- ita5290
- fre259
- spa169
- ger58
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21426
- reserved7315
- open4967
- restricted2326
- partially open90
- embargoed17
- mixed9